These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22906922)

  • 1. Anti-angiogenic gene therapy in the treatment of malignant gliomas.
    Gatson NN; Chiocca EA; Kaur B
    Neurosci Lett; 2012 Oct; 527(2):62-70. PubMed ID: 22906922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic gene therapy of malignant glioma.
    Stratmann A; Machein MR; Plate KH
    Acta Neurochir Suppl; 1997; 68():105-10. PubMed ID: 9233424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.
    Zhang M; Ye G; Li J; Wang Y
    Brain Tumor Pathol; 2015 Oct; 32(4):229-36. PubMed ID: 26437643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model.
    Wang F; Zhang S; Sun F; Chen W; Liu C; Dong H; Cui B; Li L; Sun C; Du W; Liu B; Fan W; Deng J; Schmitt CA; Wang X; Du J
    Cancer Gene Ther; 2024 Aug; 31(8):1135-1150. PubMed ID: 38926596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy of malignant glioma via inhibition of tumor angiogenesis.
    Plate KH
    Cancer Metastasis Rev; 1996 Jun; 15(2):237-40. PubMed ID: 8842496
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiogenesis in brain tumors; pathobiological and clinical aspects.
    Wesseling P; Ruiter DJ; Burger PC
    J Neurooncol; 1997 May; 32(3):253-65. PubMed ID: 9049887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma multiforme: novel therapeutic targets.
    Muir M; Gopakumar S; Traylor J; Lee S; Rao G
    Expert Opin Ther Targets; 2020 Jul; 24(7):605-614. PubMed ID: 32394767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.
    Onishi M; Kurozumi K; Ichikawa T; Date I
    Neurol Med Chir (Tokyo); 2013; 53(11):755-63. PubMed ID: 24162241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy.
    Ishikawa E; Miyazaki T; Takano S; Akutsu H
    Brain Tumor Pathol; 2021 Jul; 38(3):149-155. PubMed ID: 33977360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells.
    Gupta V; Wang W; Sosnowski BA; Hofman FM; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E26. PubMed ID: 16709032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
    Pearson JRD; Cuzzubbo S; McArthur S; Durrant LG; Adhikaree J; Tinsley CJ; Pockley AG; McArdle SEB
    Front Immunol; 2020; 11():582106. PubMed ID: 33178210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.
    Mineharu Y; King GD; Muhammad AK; Bannykh S; Kroeger KM; Liu C; Lowenstein PR; Castro MG
    Clin Cancer Res; 2011 Jul; 17(14):4705-18. PubMed ID: 21632862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for brain tumors: basic developments and clinical implementation.
    Assi H; Candolfi M; Baker G; Mineharu Y; Lowenstein PR; Castro MG
    Neurosci Lett; 2012 Oct; 527(2):71-7. PubMed ID: 22906921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model.
    Niola F; Evangelisti C; Campagnolo L; Massalini S; Buè MC; Mangiola A; Masotti A; Maira G; Farace MG; Ciafrè SA
    Cancer Biol Ther; 2006 Feb; 5(2):174-9. PubMed ID: 16340308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.
    Kaur B; Cork SM; Sandberg EM; Devi NS; Zhang Z; Klenotic PA; Febbraio M; Shim H; Mao H; Tucker-Burden C; Silverstein RL; Brat DJ; Olson JJ; Van Meir EG
    Cancer Res; 2009 Feb; 69(3):1212-20. PubMed ID: 19176395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of caveolin-1 restores myeloid cell function in human glioblastoma.
    Shimato S; Anderson LM; Asslaber M; Bruce JN; Canoll P; Anderson DE; Anderson RC
    PLoS One; 2013; 8(10):e77397. PubMed ID: 24130882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.